M. Monari
Istituto Clinico Humanitas - IRCCS, Italy
Biography
M Monari is the Director of Clinical Laboratory Analysis of Humanitas Research Hospital and she is a contract Professor of two Italian University: Humanitas University and Insubria University in Nurse degrees. She develops, in according with the hospital direction, different investigation studies around topics of health and security of blood collections and datas communications. She has more than 45 poster published and 23 articles. She was Editorial Board member for the Journal of Women’s Health and Reproductive Medicine. She was also Cheif Director or several courses and congress and speaker to them.
Abstract
Background: Between January and May 2013, 352 cases of HAV infection were notified in Italy corresponding to a 70% increase compared to the same period in 2012 [12]. Hepatitis A virus (HAV)
infection is an acute, self-limited liver disease transmitted usually through the faecal-oral route via person-to-person contact. Aim of this study is understand the actual abnormal relevation of positive cases in a selected northen Italian population in 2017.
Methods: We analyzed two different set of patients: all the results obtained in our laboratory during the 12th months of 2013 (894 patients, 65% female and 35% male) and in 12 months of 2017 (1089 patients, 63% female and 37% male) for IgM of HAV (HAVA IgM, Abbott, Architect i2000®). The range of results is less 1.0 S/Co negative, upper 1.0 S/Co positive.
Results: All the positive cases registered are arrived from emergency units of our Hospital.
Conclusion: At the light of these results we are probably observing a new epidemia. Regione Lombardia has suggested four possible causes: subject with chronic hepatitis that received concentrated treatment with coagulation factor, drugs abuse, men who have sex with men, subjects under 14 years old that have done trip. From these remarks, rescue aid becomes the crossroads for taking over and managing this epidemia, perhaps we could be largely prevented by inserting vaccination into the mandatory program.